Cleared Traditional

K933794 - ANI BIOCARD(TM) HCG TEST

K933794 is an FDA 510(k) clearance for ANI BIOCARD(TM) HCG TEST, manufactured by Canadian Bioclinical, Ltd.. The device is a Class 2 Chemistry device with product code LCX cleared through the Traditional 510(k) pathway after a 288-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
288d
Days
Class 2
Risk

K933794 is an FDA 510(k) clearance for the ANI BIOCARD(TM) HCG TEST. Classified as Kit, Test, Pregnancy, Hcg, Over The Counter (product code LCX), Class II - Special Controls.

Submitted by Canadian Bioclinical, Ltd. (Ontario, Canada, CA). The FDA issued a Cleared decision on May 19, 1994 after a review of 288 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K933794

510(k) Number K933794 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1993
Decision Date May 19, 1994
Days to Decision 288 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
199d slower than avg
Panel avg: 89d · This submission: 288d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCX Device Classification - Class 2, Special Controls

Product Code LCX Kit, Test, Pregnancy, Hcg, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LCX Kit, Test, Pregnancy, Hcg, Over The Counter

All 225
Devices cleared under the same product code (LCX) and FDA review panel - the closest regulatory comparables to K933794.
PREGNANCY CHECK
K941355 · Sa Scientific, Inc. · Jul 1994
BODYWISE PREGNANCEY TEST
K941771 · Charlton Assoc. · Jul 1994
PREDICTOR HOME PREGNANCY TEST
K940637 · Organon Teknika Corp. · Jun 1994
EVATEST STRIP
K936013 · Boehringer Mannheim Italia Spa · Feb 1994
ADVANCE PREGNANCY TEST MODIFICATION
K934516 · Ortho Pharmaceutical Corp. · Feb 1994
HCG PREGNANCY ONE STEP TEST STRIP
K934830 · Tcpi, Inc. · Dec 1993